$1.150
-0.140 (-12.21%)終値時点
SL Science Holding Reports Positive Data for Glioblastoma Treatment
SL Science Holding Files New Drug Master File with FDA
SL Science Files New Drug Master File with FDA
Biotech Stocks Surge with Significant Gains
SL Science Showcases γδ T Cell Therapy for Glioblastoma
SL Science Submits Orphan Drug Designation for Brain Cancer Treatment
SL Science Holding Submits Orphan Drug Designation for GBM Therapy
Biotech Companies See Significant Stock Gains
SL Science Reports 2025 Financial Results and Strategic Shift
Biotech Companies Achieve Significant Milestones
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。